Strong And Rising: Halozyme Therapeutics Stock May Have More Upside
Halozyme Therapeutics stock is a solid choice to leverage the current momentum. It offers strong margins, low-debt capital structure, reasonable valuation, and momentum.
(Forbes, 2025-10-10T12:19:33Z)